128899-31-0 Usage
Description
(+)-D-PYROGLUTAMOL P-TOLUENESULFONATE is a chiral organic compound derived from pyroglutamic acid. It is characterized by the presence of a pyroglutamol amino acid in its molecular structure and a p-toluenesulfonate (tosylate) functional group, which enhances its solubility in organic solvents and acts as a leaving group in chemical reactions. The "(+)-D" designation indicates the compound's specific optical rotation and configuration, distinguishing it as a chiral molecule.
Uses
Used in Chemical Synthesis:
(+)-D-PYROGLUTAMOL P-TOLUENESULFONATE is used as a reagent or intermediate in the synthesis of various organic compounds. Its unique structural features and the tosylate group's reactivity make it a valuable component in the preparation of complex molecules.
Used in Pharmaceutical Applications:
(+)-D-PYROGLUTAMOL P-TOLUENESULFONATE is used as a building block or a key component in the development of new pharmaceuticals. Its chiral nature and the presence of the amino acid pyroglutamol may contribute to the compound's potential biological activity and therapeutic effects.
Used in Materials Science:
(+)-D-PYROGLUTAMOL P-TOLUENESULFONATE is used as a component in the design and synthesis of novel materials with specific properties. Its structural characteristics and the ability to interact with other molecules can lead to the creation of materials with tailored properties for various applications.
Check Digit Verification of cas no
The CAS Registry Mumber 128899-31-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,8,8,9 and 9 respectively; the second part has 2 digits, 3 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 128899-31:
(8*1)+(7*2)+(6*8)+(5*8)+(4*9)+(3*9)+(2*3)+(1*1)=180
180 % 10 = 0
So 128899-31-0 is a valid CAS Registry Number.
128899-31-0Relevant articles and documents
NOVEL FUNCTIONALIZED LACTAMS AS MODULATORS OF THE 5-HYDROXYTRYPTAMINE RECEPTOR 7 AND THEIR METHOD OF USE
-
Paragraph 000723, (2021/05/21)
Described herein are new, selective modulators of the 5 -HT7 receptor. These selective compounds can be useful for the treatment of CNS and non-CNS indications. Compounds described herein can be selective in targeting 5-HT7 receptors
NOVEL FUNCTIONALIZED LACTAMS AS MODULATORS OF THE 5-HYDROXYTRYPTAMINE RECEPTOR 7 AND THEIR METHOD OF USE
-
Paragraph 01130, (2019/11/28)
Pharmaceutical compositions of the invention comprise functionalized lactam derivatives of formula (I) having a disease-modifying action in the treatment of diseases associated with dysregulation of 5- hydroxytryptamine receptor 7 activity. A is selected
MUSCARINIC AGONISTS
-
Page/Page column 45, (2017/02/28)
This invention relates to compounds that are agonists of the muscarinic M4 receptor and/or M4 receptor and which are useful in the treatment of muscarinic M1/M4 receptor mediated diseases. Also provided are pharmaceutical compositions containing the compounds and the therapeutic uses of the compounds. Compounds include those according to formula 1a or a salt thereof, wherein n, p, Q, R1, R2, R3, R9 and R4 are as defined herein.
